Jurassic Coast Challenge
Join 2,000 adventurers of all experience levels & ages and walk, jog or run 25, 50 or 100km of the spectacular Jurassic Coast – a World Heritage Site.
Search results
Join 2,000 adventurers of all experience levels & ages and walk, jog or run 25, 50 or 100km of the spectacular Jurassic Coast – a World Heritage Site.
Mark your special day, whilst fundraising for people with inherited sight loss.
Thursday 5 February 2026, 7.00pm - 8.00pm - via Zoom - Please come and join us for a Scotland region-wide meeting where we are delighted to introduce our new Glasgow Peer Support Group facilitator, Sarah Speed.
The following projects were being funded by Retina UK and have recently come to an end.
When we talk about gene therapy we are usually referring to use of a harmless virus, called a vector, to deliver a normal copy of a defective gene into the cells of the eye.
Prof Mariya Moosajee at Moorfields Eye Hospital has asked us to share the message below about the clinical trial she is running. This trial is for a treatment that targets a particular section of the USH2A gene.
Biotechnology company ProQR has announced encouraging results from its early analysis of the phase 1/2 trial of QR-421a, an innovative approach to treating sight loss caused by mutations in a particular section of the USH2A gene.
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Our monthly e-Newsletter featuring the latest updates from Retina UK.
This July, Ben Ramus will lead a group of twelve adventurers as they take on the renowned National Three Peaks Challenge, in aid of national sight loss charity, Retina UK. Ben has decided to take on the epic challenge in recognition of two of his uncles’ sight loss journey, as they live with the rare inherited sight loss condition, retinitis pigmentosa.